Controle de qualidade em cirurgia cardiovascular: um paradigma a ser atingido
Quality control in cardiovascular surgery: a new paradigm
AbstractThe objective is to write a literature review of the relevant information related to quality control in cardiovascular surgery. The authors have studied several parameters to allow quality control in cardiovascular surgery: 1. Construction of a database as complete as possible to the similar ones of the Society of Thoracic Surgeons and the European Association for Cardio-thoracic Surgery; 2. To create a surgical risk model like the Euroscore; 3. To make an analysis of the different reasons for a poor surgical outcomes and try to correct them; 4. To study the human factor as an important element to the surgical outcome and discuss methods to avoid erros in an action similar to the ones used in aviation. Enabling a tight control of quality in cardiovascular surgery it is possible to obtain a major improvement in surgical outcomes.
471MURAD, H ET AL -Quality control in cardiovascular surgery: a new paradigm Bras Cir Cardiovasc 2007; 22(4): 470-475
Rev
The authors recommend the single-stage early management of sternotomy infected wounds with debridement, drainage and immediate closure of the wound using bilateral pectoralis major myocutaneous advancement flaps to the medium line of the sternum. The procedure is effective and may contribute to decrease the morbidity.
Background: Heart failure can present with asymptomatic dysfunction at decompensation, with limitations and decrease in the productive capacity. The Continuous Positive Airway Pressure (CPAP) is a non-pharmacological means to decrease afterload.
Bicuspid aortic valve (BAV) is associated with annuloaortic ectasia, dissection and ascending aortic aneurysm. The high incidence of this congenital malformation and aortic disease suggests a close correlation between the two phenomena. Abnormalities in different phases of cell migration of the neural crest might be responsible for the occurrence of abnormalities in the aortic valve, media layer of the ascending aorta and vessels of the aortic arch. Previous studies have shown that patients with normal BAV or slight dysfunction may present with dilation of the aortic root. The hemodynamic changes caused by BAV without stenosis or insufficiency seem to be an insufficient explanation for these findings. Several mechanisms have been proposed to explain the molecular and hystological aspects of this disease. We found a reduced fibrillin-1 content in both ascending aorta and pulmonary trunk as a possible cause. Histologically, the ascending aorta can present cystic medial necrosis and elastic fragmentation, similar to Marfan's disease. Some authors concluded that many patients, mainly those with aortic regurgitation, should have the aortic valve and the ascending aorta replaced at the same procedure, even if a mild dilatation (45 mm) is present in patients with BAV if life expectancy is anticipated to be greater than 10 years to prevent further aneurysms or ruptures.
Abstract:Purpose: Bicuspid aortic valve (BAV) is associated with increased prevalence of annulo-aortic ectasia, dissection and ascending aortic aneurysm. This study was undertaken to compare the amount of fibrillin-1 and elastin in the media of great vessels of patients with bicuspid and tricuspid aortic valve disease. Method: Tissue samples of ascending aorta and pulmonary artery were obtained from 22 patients with bicuspid aortic valve disease (BAV) and 17 patients with tricuspid aortic valve disease (TAV), including 6 normal valves from the transplant program. Indirect immunofluorescence and computerized image analyses were used to quantify fibrillin-1 and elastin of the media of the arteries. The results were expressed as the mean integrated optical density (IOD). Results: In the ascending aorta, the IOD for fibrillin-1 was 15 ± 8 in the BAV group and 24 ± 7 in the TAV group (p = 0.001). In the pulmonary artery, the IOD for fibrillin-1 was 18 ± 10 in the BAV group and 25 ± 9 in the TAV group (p = 0.07). In respect to the elastin measurements of the aorta, the specific IOD was 34 ± 13 in the BAV group and 29 ± 14 in the TAV group. In the pulmonary artery the IOD for elastin was 30 ± 12 in the BAV group and 29 ± 14 in the TAV group (p = 0.34). Conclusions: Patients with BAV were found to have less fibrillin-1 in the ascending aorta and pulmonary artery than patients with TAV. These findings may explain aortic root dilation and ascending aortic dissection in patients with BAV disease.Descriptors: Aortic valve, pathology. Aorta, aneurysm, dissection, surgery. Fibrillin. Elastin. Marfan syndrome.
ResumoObjetivo: A valva aórtica bicúspide (VAB) está associada a maior prevalência de ectasia anulo-aórtica, aneurisma e dissecção da aorta ascendente. Este estudo investigou a quantidade de fibrilina-1 e elastina nos grandes vasos de portadores de VAB.Método: Amostras de tecidos foram colhidas da aorta ascendente e tronco da artéria pulmonar de 22 portadores de VAB e 16 portadores de valva aórtica tricúspide (VAT) submetidos a cirurgia cardíaca, incluindo seis portadores de valva aórtica normal, provenientes do programa de transplante. Imunofluorescência indireta e análise computadorizada de imagens foram utilizadas para Rev Bras Cir Cardiovasc 2003; 18(2): 148-156
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.